Skip to main content
. 2018 Aug 9;11(4):335–343. doi: 10.1159/000488880

Table 2.

Results of sibutramine therapy in patients split by BMI category

Treatment duration BMI 25–29.9 kg/m2 BMI 30–34.9 kg/m2 BMI 35–39.9 kg/m2 BMI > 40 kg/m2
3 months
 Body weight loss, kg −7.13 ± 3.10* −8.54 ± 3.39 −9.97 ± 4.2 −11.94 ± 5.72
 Body weight change, % −8.75 ± 3.79 −9.32 ± 3.60 −9.72 ± 3.95 −10.05 ± 4.5
 BMI change, kg/m2 −2.51 ± 1.09 −3.05 ± 1.19 −3.61 ± 1.48 −4.37 ± 2.06

6 months
 Body weight loss, kg −10.71 ± 4.21 −13.35 ± 4.87 −15.97 ± 6.07 −19.03 ± 7.88
 Body weight change, % −13.07 ± 4.99 −14.56 ± 5.13 −15.56 ± 5.67 −16.02 ± 6.34
 BMI change, kg/m2 −3.75 ± 1.45 −4.77 ± 1.71 −5.78 ± 2.13 −6.96 ± 2.82

12 months
 Body weight loss, kg −12.93 ± 5.05 −16.84 ± 6.05 −21.10 ± 7.96 −26.13 ± 10.99
 Body weight change, % −15.7 ± 5.9 −18.26 ± 6.29 −20.46 ±7.38 −21.90 ± 8.85
 BMI change, kg/m2 −4.5 ±1.71 −6.0 ± 2.11 −7.61 ± 2.80 −9.52 ± 3.89
*

Data are presented as the mean ± SD.